Intervention not reported
Quality of life up to 28 days and longest · hospitalized people with mild to moderate symptomatic COVID‐19 (WHO scale 2 to 4) with severe comorbidities
The review found no eligible studies for this question.
1 finding from 1 review
- Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found